SAFETY AND IMMUNOGENICITY OF BNT162B2 MRNA COVID-19 VACCINE AMONG ADOLESCENTS WITH RHEUMATIC DISEASES TREATED WITH IMMUNOMODULATORY MEDICATIONS

被引:0
|
作者
Heshin-Bekenstein, M. [1 ,2 ]
Ziv, A. [2 ,3 ]
Toplak, N. [4 ]
Hagin, D. [2 ,5 ]
Kadishevich, D. [6 ]
Butbul, Y. [7 ]
Saiag, E. [8 ]
Shefer, G. [9 ]
Sharon, O. [9 ]
Pel, S. [10 ]
Elkayam, O. [2 ,10 ]
Uziel, Y. [2 ,3 ]
机构
[1] Dana Dwek Childrens Hosp, Pediat Rheumatol Serv, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Meir Med Ctr, Pediat Rheumatol Unit, Kefar Sava, Israel
[4] Univ Childrens Hosp, Univ Med Ctr Ljubljana, Dept Allergol Rheumatol & Clin Immunol, Ljubljana, Slovenia
[5] Tel Aviv Med Ctr & Sch Med, Allergy & Clin Immunol Unit, Tel Aviv, Israel
[6] Meir Med Ctr, Pediat, Kefar Sava, Israel
[7] Ruth Rappaport Childrens Hosp, Pediat Rheumatol Serv, Rambam Med Ctr, Haifa, Israel
[8] Tel Aviv Sourasky Med Ctr, Hosp Management, Informat & Operat Branch, Tel Aviv, Israel
[9] Tel Aviv Sourasky Med Ctr, Dept Endocrinol Metab & Hypertens, Tel Aviv, Israel
[10] Tel Aviv Sourasky Med Ctr, Dept Rheumatol, Tel Aviv, Israel
关键词
D O I
10.1136/annrheumdis-2022-eular.4691
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS0258
引用
收藏
页码:370 / 371
页数:2
相关论文
共 50 条
  • [21] Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients
    Basson, Yael Pri-Paz
    Tayar-Shifman, Oshrat E.
    Naser, Rawand
    Matalon, Shelly Tartakover
    Kimhi, Oded
    Gepstein, Raz
    Halperin, Tamar
    Ziv-Baran, Tomer
    Ziv, Amit
    Parikh, Roma
    Kivity, Shaye
    Levy, Yair
    CLINICAL RHEUMATOLOGY, 2022, 41 (12) : 3879 - 3885
  • [22] Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients
    Yael Pri-Paz Basson
    Oshrat E. Tayer-Shifman
    Rawand Naser
    Shelly Tartakover Matalon
    Oded Kimhi
    Raz Gepstein
    Tamar Halperin
    Tomer Ziv-Baran
    Amit Ziv
    Roma Parikh
    Shaye Kivity
    Yair Levy
    Clinical Rheumatology, 2022, 41 : 3879 - 3885
  • [23] Immunogenicity and safety of the BNT162b2 COVID-19 mRNA vaccine in PLWH: A monocentric study in Bari, Italy
    Milano, Eugenio
    Ricciardi, Aurelia
    Casciaro, Raffaella
    Pallara, Elisabetta
    De Vita, Elda
    Bavaro, Davide F.
    Larocca, Angela Maria Vittoria
    Stefanizzi, Pasquale
    Tafuri, Silvio
    Saracino, Annalisa
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 2230 - 2236
  • [24] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Danylesko, Ivetta
    Litachevsky, Vladislav
    Levy, Itzchak
    Olmer, Liraz
    Lusitg, Yaniv
    Avigdor, Abraham
    Nagler, Arnon
    Shimoni, Avichai
    Rahav, Galia
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (04) : 884 - 891
  • [25] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
    Levy, Itzchak
    Wieder-Finesod, Anat
    Litchevsky, Vladyslav
    Biber, Asaf
    Indenbaum, Victoria
    Olmer, Liraz
    Huppert, Amit
    Mor, Orna
    Goldstein, May
    Levin, Einav Gal
    Hod, Tammy
    Cohen, Carmit
    Lustig, Yaniv
    Rahav, Galia
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1851 - 1855
  • [26] Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy
    Sugihara, Koichi
    Wakiya, Risa
    Shimada, Hiromi
    Kameda, Tomohiro
    Nakashima, Shusaku
    Kato, Mikiya
    Miyagi, Taichi
    Mizusaki, Mao
    Mino, Rina
    Nomura, Yumi
    Inoo, Masayuki
    Kadowaki, Norimitsu
    Dobashi, Hiroaki
    INTERNAL MEDICINE, 2022, 61 (13) : 1953 - 1958
  • [27] Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine
    Schmeling, Max
    Manniche, Vibeke
    Hansen, Peter Riis
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (12)
  • [28] Humoral response and safety of BNT162b2 mRNA vaccine in children with rheumatic diseases
    Akgun, Ozlem
    Cakmak, Figen
    Guliyeva, Vafa
    Demirkan, Fatma Gul
    Tanatar, Ayse
    Hancerli Torun, Selda
    Cin, Dilan
    Mese, Sevim
    Agacfidan, Ali
    Aktay Ayaz, Nuray
    RHEUMATOLOGY, 2022, 61 (11) : 4482 - 4490
  • [29] Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine
    Schmeling, Max
    Manniche, Vibeke
    Hansen, Peter Riis
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (08)
  • [30] BNT162b2 COVID-19 vaccine
    不详
    AUSTRALIAN PRESCRIBER, 2021, 44 (02) : 57 - 58